I am currently Chief Physician and Director of Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine. My primary research focus lies in leading both clinical trials and translational research in cellular immunotherapy. This dual focus ensures that our clinical work is informed by mechanistic insights, and our laboratory discoveries are grounded in and guided by real-world patient data. In the realm of clinical research, I lead a substantial portfolio of early-phase trials. Serving as Principal Investigator for over ten registered and investigator-initiated clinical studies in solid tumor cellular therapy, I have overseen the enrollment of more than 170 patients

Based on my foundational work in clinical and translational research, I hosted 2 General Programs of the National Natural Science Foundation of China, 2 sub-projects of the Key Research and Development Program of the Ministry of Science and Technology, 2 key sub-projects of the 2030 Major Project, and 3 Key Research and Development Projects in Zhejiang Province. Moving forward, I remain committed to advancing this virtuous cycle of clinical-translational integration.

Google Scholar Metrics: h-index: 40, i10-index: 88

Clinical and translational research on innovative cell therapies for solid tumors

2024 Zhejiang Provincial Natural Science Award, Second Class (Provincial/Ministerial Level). Project: "Mechanism of Antiviral Immune Regulation in the Process of Liver Disease Severification". Recipients: Dianhong Yan, Zhang Jian, Meng Yuting, Weijia Fang, Zhao Huajun. Date: Nov 22, 2024.

1. National Health Commission (NHC) Capacity Building and Continuing Education Center for Oncology Committee: Member

2. Chinese Society of Clinical Oncology (CSCO): Council Member

3. CSCO Foundation for Clinical Oncology Research: Council Member

4. CSCO Liver Cancer Expert Committee: Vice Chairperson

5. China Pharmaceutical Innovation and Research Development Association (PhIRDA), Anti-tumor Drug Clinical Research Professional Committee: Standing Committee Member

6. CSCO Biliary Tract Cancer Expert Committee: Standing Committee Member

7. Zhejiang Medical Association, Oncology Chemotherapy & Biotherapy Branch: Vice Chairperson

8. Zhejiang Medical Doctors Association, Evidence-Based Medicine Professional Committee: Vice Chairperson

9. Zhejiang Anti-Cancer Association, Integrated Oncology Professional Committee: Vice Chairperson

10. Journal of Clinical Oncology (Chinese Edition): Executive Editorial Board Member

11. Western Returned Scholars Association (WRSA), Physician Branch, Hepatobiliary Division: Standing Committee Member

12. China International Exchange and Promotive Association for Medical and Health Care (CPAM), Neuroendocrine Tumor Branch: Standing Committee Member

13. American Society of Clinical Oncology (ASCO): Member

14. European Society for Medical Oncology (ESMO): Member

15. Indiana University, USA: Visiting Scholar

16. The University of Hong Kong: Visiting Scholar